IQHQ, a prominent developer of life science districts, secured $900 million in new capital during 2024, with the final round closing in December. This funding is expected to bolster the company’s efforts in providing state-of-the-art laboratory and research spaces equipped with top-tier amenities and convenient transportation access.
The capital raise followed a strong year of leasing activity, during which IQHQ finalized 400,000 square feet of life science and retail leases. The additional funding positions the company to capitalize on favorable market trends in the life science sector, which continues to show significant growth. IQHQ has also reported a surge in active negotiations and prospective opportunities for future developments.
Tyler Rose, President and CFO, IQHQ: “These capital rounds, led by our existing institutional equity investors, highlight their continued confidence in our business model and the promising outlook for life science real estate. The ability to raise and allocate substantial capital reinforces the strength of our strategy, team, and innovation-focused projects.”
Stephen Rosetta, Co-CEO and Co-Founder, IQHQ: “Our urban innovation hubs attract industry leaders by providing flexible research spaces to drive advancements in health and technology. With key projects on track for the first quarter of 2025, we are well-positioned to execute our strategy and strengthen our reputation as a leading developer of world-class life science districts.”
If you are a proptech company and want to promote your products for free, go to proptechbuzz.com and submit your products. For investors or proptech buyers, sign up on our platform to stay informed about exciting updates and trends in the Proptech Ecosystem.
Explore more Proptech news at proptechbuzz.com/news, for news tips and promotions, reach out to marketing@proptechbuzz.com.
By Proptechbuzz
By Ravi Kumar
